MarginsXMarginsX
Home › Markets › CLCS

Cell Source, Inc. (CLCS)

CLCS is quoted over the counter, not listed on an exchange. Cell Source, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 10, 2026
$0.4400
No trades since Nov 10, 2026; later closes repeat the last quote
1-year return
+15.0%
Market cap
$29.9M
Nano cap. From the Nov 10, 2026 last trade × 67.9M shares (10-Q cover page, May 13, 2026)
P/E and P/S
Latest financials end 2025-03-31, over 15 months ago · Latest financials end 2025-03-31, over 15 months ago
On trailing twelve months to March 31, 2025 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerCLCS, quoted over the counter
SEC CIK0001569340
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressNew York, NY
Incorporated inNV

Warning signs

Cash runway
0.0 months
$1K cash at March 31, 2025
Share count, 1 year
No year-earlier count
+78.0% over 3 years
Going-concern doubt
Yes
10-Q filed May 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date these financial statements are issued."
10-Q 2026-05-14
Cash and burn$1K cash; operating cash flow -$778K a quarter.Report 2025-03-31
Shares outstanding67,945,856 (2026-05-13); 38,163,385 three years earlier.Cover page 2026-05-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., New York, New York, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2025
2025-03-31
Not filed-$1.5M-$600K$1KNo debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2024
2024-12-31
Not filed-$331K-$748K$75KNo debt tagsNeeds four quarters10-K 2026-04-07
Q3 2024
2024-09-30
Not filed-$1.4M-$639K$23KNo debt tagsNeeds four quarters10-Q 2024-11-14
Q2 2024
2024-06-30
Not filed-$1.5M-$1.1M$91KNo debt tagsNeeds four quarters10-Q 2024-11-14
Q1 2024
2024-03-31
Not filed-$1.3M-$174K$23No debt tagsNeeds four quarters10-Q 2026-05-14
Q4 2023
2023-12-31
Not filed-$1.0M-$722K$22KNo debt tagsNeeds four quarters10-K 2026-04-07
Q3 2023
2023-09-30
Not filed-$1.3M-$280K$3KNo debt tagsNeeds four quarters10-Q 2024-11-14
Q2 2023
2023-06-30
Not filed-$1.2M-$1.0M$22KNo debt tagsNeeds four quarters10-Q 2024-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32014-11-12
Latest annual report10-K2026-04-07
Latest quarterly / interim10-Q2026-05-14
Latest current report8-K2025-06-27

Source: SEC EDGAR submissions feed, 139 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier